300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Renewable Energy
Legal
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Recruiting
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Sweden
Romania
Oceania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Europe
Qatar
Peru
Slovenia
San Marino
Ukraine
Angola
Cyprus
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Broadhi Capital, VC Fund

Broadhi Capital

VC Fund

Shanghai, China

Broadhi Capital is a venture capital and private equity firm specializing in growth and mature stage investments. For mature companies, the firm seeks to invest in firms that are in Pre-IPO stage and can be listed in an IPO within 2-3 years. For growth companies, it seeks to invest in firms that can be listed in an IPO within 1-3 years. The firmprefers to invest in biomedical, biotechnology, new consumer, energy conservation, clean technology, new materials, advanced manufacturing, medical treatment, environment protection, electronic information technology, energy saving, equipment, consumer, new materials, and modern agriculture industry. It typically invests in companies based in China, especially in Henan Province. The firm seeks to have a minority stake of 35% or lower in their portfolio companies. Broadhi Capital was founded on July 2008 and is based in Shanghai, China with additional offices in Beijing, China and Zhengzhou, China.

Total investments:
16
Last investment:
Lead investor:
13%
Last fund:

Last updated:

Industries Broadhi Capital invests in

Health CareMedicalMobileManufacturingAgriculture

Stages Broadhi Capital invests in

AngelSeries ASeries BSeedSeries C

Countries Broadhi Capital invests in

China

Round sizes

Angel $229k–$5.3MSeries A $226k–$44M

Round size

Angel
$229k–$5.3M
Series A
$226k–$44M

Investment Focus

Industry

  • Health Care 7 (44%)
  • Medical 6 (38%)
  • Mobile 4 (25%)
  • Manufacturing 4 (25%)
  • Agriculture 2 (13%)
See all 25 industries →

Stage

  • Angel 5 (31%)
  • Series A 5 (31%)
  • Series B 2 (13%)
  • Seed 1 (6%)
  • Series C 1 (6%)
See all 6 stages →

Investments

CompanyDescriptionRoundLinks
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. Series A / Nov 28, 2020
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products,pesticides, etc., and has contributed to the promotion and development of green chemistry. Series A / Apr 03, 2019
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providingbio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services. $43.6M / Series A / Jan 01, 2019
Jinyu Medical focuses on remote clinics and family doctor services. $207.6K / Seed / Oct 24, 2018
Sinagri YingTai is a producer of green alternative products that conducts research and development in the fields of animal nutrition, biological veterinary medicine, biological medicine, health care products, cosmetics, and other fields. Their products include animal health, veterinary medicine, and raw materials. Series B / Jul 23, 2018
Fansheng Tuxiang company has a number of wholly-owned subsidiaries as well as R&D centers, laboratories, and offices. They offer a modular design and a tool-based application platform to quickly and affordably implement the laboratory standard in the mass production process. $3M / Series B / Jul 20, 2016
TM' Holter is an application development of intelligent biosensing systems. $1.6M / Series A / Oct 22, 2015
Panther Healthcare develops and manufactures surgical stapling and minimally invasive endo surgery products. $17.5M / Series A / Jun 19, 2015
Cooee Technology is a mobile game developer company. $485.4K / Angel / May 29, 2015
uliaobao provides online sales of fabric products. They provide cotton, woolen blended fabrics, chemical fabrics, and others. They allow consumers to directly buy goods or services from a seller over the internet using a web browser or a mobile app. Their products serve consumers. $5.3M / Angel / May 29, 2015
See all 16 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Software
Renewable Energy
Legal
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Recruiting
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Sweden
Romania
Oceania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Europe
Qatar
Peru
Slovenia
San Marino
Ukraine
Angola
Cyprus
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Broadhi Capital invest in?

Broadhi Capital invests primarily in Health Care, Medical and Mobile startups, most often at Angel and Series A stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Broadhi Capital invest in?

Broadhi Capital typically joins rounds of $229k–$5.3M at Angel and $226k–$44M at Series A. These are whole funding-round sizes, not Broadhi Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Broadhi Capital took part in.

When did Broadhi Capital last invest?

The most recent investment recorded for Broadhi Capital closed in Nov 2020. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Broadhi Capital Broadhi Capital Find emails